
Govt courts Japan to make drugs in India
After regular but failed attempts to push pharmaceuticals exports to Japan, the central government is now set to attract Japanese companies to come and ‘Make in India’.
While government is already in talks with 20 Japanese companies to establish contract manufacturing businesses in India, a new set of delegation will visit Japan in August to attract more companies and boost them with a fresh dose of confidence.
Japan has always remained a tough market for Indian drug exports, which fell drastically by 20% in 2014-15. The market had registered moderate growth till 2012-13 with an average growth of over 8.5%.
“Japan has a different mindset about our quality of generics and it has been very tough to push our exports there. However, now we are negotiating with the Japanese government to come and manufacture drugs in India and utilise our low cost services. This will boost ‘Make in India’ initiative,” said PV Appaji, director general, Pharmexcil. “In next two months, we will follow up with those 20 companies which showed their interest to establish contract manufacturing in India during our visit in April.”
“We also plan to attract new set of companies there. For this we will hold fresh round of talks with Japanese health regulators,” he added.
Being the second largest pharmaceutical market with one of the largest per capita spending on medicines in the world ($886 in 2013), Japan has remained a focus market for the Indian pharmaceutical industry.
Otherwise, United States tops the list of countries importing Indian generics followed by UK, Germany, Russia and Nigeria.
In 2013-14, the industry had an export turnover of `90,000 crore and government expects to cross Rs 1,00,000 crore by this year.

US SC to look into system that lets corporations like Apple kill patent lawsuits
- In an argument at the intersection of intellectual property and the separation of powers, the justices on Monday will consider a challenge to a congressionally-created board that critics have dubbed a “death squad” because of its tendency to toss out patents.

Warren Buffett says 'never bet against America' in annual letter to shareholders

Reliance partners with Google, Facebook for digital payment network bid
- Facebook and Google are already partnered with Reliance and own stakes in Jio Platforms

ByteDance to hire 13k new employees, explore China's education technology

Texas’s power market is $1.3 billion short after energy crisis

McDonald's to sell part of its artificial intelligence start-up

Mukesh Ambani is again richest Asian as China’s Zhong loses $22 billion

Weekly wrap: After early surge, gold prices fall for last 3 days
- Gold set off to a brighter start at the beginning of the week as the price of the precious metal went up by ₹278 to ₹46,013 per 10 grams on Monday.

RBI in favour of retaining inflation target for 5 years

Telecom sector revenues back at pre-Jio levels

Indian shares crash as panic grips bond, global markets

India out of recession as GDP expands 0.4% in Q3

'Hit by double whammy of low growth, high inflation': Cong on economy's state

India's NSE defends reopening market after exchange's shutdown
